Loading clinical trials...
Loading clinical trials...
A Randomized Phase 2 Study of Anti-IL-8 Therapy Versus Standard of Care in the Treatment of Hospitalized Patients With Severe COVID-19
Conditions
Interventions
BMS-986253
Locations
1
United States
Columbia University Irving Medical Center
New York, New York, United States
Start Date
April 16, 2020
Primary Completion Date
March 1, 2021
Completion Date
March 1, 2021
Last Updated
May 22, 2025
NCT06898450
NCT05720117
NCT06658951
NCT05223608
NCT05719558
NCT06625775
Lead Sponsor
Columbia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions